FDA recalls eye drops over possible 'foreign substance'
The FDA has issued a nationwide recall for 2.5 million bottles of prescribed steroid eye drops due to sterility concerns and potential foreign substances.
22 trends tracked about this subject — the full history, oldest to newest below.
The FDA has issued a nationwide recall for 2.5 million bottles of prescribed steroid eye drops due to sterility concerns and potential foreign substances.
The FDA has issued a nationwide recall of 2.5 million bottles of eye drops following concerns over a potential foreign substance.
Venezuela grapples with the aftermath of a major earthquake as the confirmed death toll reaches 3,811 and recovery operations shift toward long-term challenges.
A mother of three reports being misdiagnosed by two GPs before receiving a stage four cancer diagnosis linked to severe bloating.
Biohacker Bryan Johnson has disclosed a diagnosis of an incurable autoimmune stomach disease.
Thousands of nurses and home care workers at Mass General Brigham are set to strike starting July 8.
The NHS is integrating AI into its app to direct patients to the most appropriate healthcare services.
The National Institutes of Health has launched the world's largest integrated health database, promising to revolutionize healthcare research.
Global health organizations have released an updated definition of heart failure, aiming to enhance prevention and care.
Starting July 1, 2026, Medicare will cover GLP-1 weight-loss drugs for seniors, marking a significant expansion in obesity treatment access.
A Louisiana man is the first in the state to be functionally cured of sickle cell disease.
Employers are reconsidering coverage for popular GLP-1 weight loss drugs, leaving patients and insurers in limbo.
Lilly, Johnson & Johnson and AbbVie stocks reach unprecedented levels as investors shift from tech to healthcare.
New research indicates that GLP-1 receptor agonists, including Ozempic, are being misused by individuals with eating disorders.
Doctors are increasingly interested in wearable data to inform patient care.
A new study questions the effectiveness of many IVF add-on treatments, sparking debate in fertility circles.
Speculation swirls around a 79-year-old patient who received an experimental weight loss drug, with former President Trump as the suspected recipient.
The NHS is expanding access to high-powered radiotherapy for thousands of men with prostate cancer to reduce treatment times.
Medicare's new pilot program expands access to GLP-1 drugs, sparking coverage on eligibility and potential impacts.
UnitedHealth is investing $3 billion in AI to automate doctor communications, sparking industry discussion.
A six-year-old Ebola patient and her mother were abducted from a hospital in DR Congo, raising concerns about the outbreak's containment.
Medical AI is shifting toward autonomous agentic systems capable of matching or surpassing human doctors in providing clinical advice.